Legend Price To Sales Ratio from 2010 to 2024

LEGN Stock  USD 56.93  1.03  1.84%   
Legend BiotechCorp Price To Sales Ratio yearly trend continues to be very stable with very little volatility. Price To Sales Ratio is likely to grow to 66.30 this year. Price To Sales Ratio is a valuation ratio that compares a company’s stock price to its revenues, calculated by dividing the company’s market cap by its total sales or revenue over a 12-month period. View All Fundamentals
 
Price To Sales Ratio  
First Reported
2010-12-31
Previous Quarter
37.15643239
Current Value
66.3
Quarterly Volatility
12.09978661
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Legend BiotechCorp financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Legend main balance sheet or income statement drivers, such as Tax Provision of 268.9 K, Interest Expense of 22.9 M or Selling General Administrative of 112.1 M, as well as many exotic indicators such as Price To Sales Ratio of 66.3, Dividend Yield of 0.0 or Operating Cycle of 268. Legend financial statements analysis is a perfect complement when working with Legend BiotechCorp Valuation or Volatility modules.
  
This module can also supplement Legend BiotechCorp's financial leverage analysis and stock options assessment as well as various Legend BiotechCorp Technical models . Check out the analysis of Legend BiotechCorp Correlation against competitors.
To learn how to invest in Legend Stock, please use our How to Invest in Legend BiotechCorp guide.

Latest Legend BiotechCorp's Price To Sales Ratio Growth Pattern

Below is the plot of the Price To Sales Ratio of Legend BiotechCorp over the last few years. Price to Sales Ratio is figured by comparing Legend BiotechCorp stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Legend BiotechCorp sales, a figure that is much harder to manipulate than other Legend BiotechCorp multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. It is a valuation ratio that compares a company’s stock price to its revenues, calculated by dividing the company’s market cap by its total sales or revenue over a 12-month period. Legend BiotechCorp's Price To Sales Ratio historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Legend BiotechCorp's overall financial position and show how it may be relating to other accounts over time.
ViewLast Reported 35.57 X10 Years Trend
Slightly volatile
   Price To Sales Ratio   
       Timeline  

Legend Price To Sales Ratio Regression Statistics

Arithmetic Mean68.69
Geometric Mean67.39
Coefficient Of Variation17.61
Mean Deviation8.53
Median75.31
Standard Deviation12.10
Sample Variance146.40
Range38.1494
R-Value(0.60)
Mean Square Error100.99
R-Squared0.36
Significance0.02
Slope(1.62)
Total Sum of Squares2,050

Legend Price To Sales Ratio History

2024 66.3
2023 37.16
2022 67.86
2021 73.11
2020 43.86
2019 64.35

About Legend BiotechCorp Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Legend BiotechCorp income statement, its balance sheet, and the statement of cash flows. Legend BiotechCorp investors use historical funamental indicators, such as Legend BiotechCorp's Price To Sales Ratio, to determine how well the company is positioned to perform in the future. Although Legend BiotechCorp investors may use each financial statement separately, they are all related. The changes in Legend BiotechCorp's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Legend BiotechCorp's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Legend BiotechCorp Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Legend BiotechCorp. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for 2024
Price To Sales Ratio 37.16  66.30 

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Legend BiotechCorp offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Legend BiotechCorp's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Legend Biotechcorp Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Legend Biotechcorp Stock:
Check out the analysis of Legend BiotechCorp Correlation against competitors.
To learn how to invest in Legend Stock, please use our How to Invest in Legend BiotechCorp guide.
Note that the Legend BiotechCorp information on this page should be used as a complementary analysis to other Legend BiotechCorp's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the AI Investment Finder module to use AI to screen and filter profitable investment opportunities.

Complementary Tools for Legend Stock analysis

When running Legend BiotechCorp's price analysis, check to measure Legend BiotechCorp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Legend BiotechCorp is operating at the current time. Most of Legend BiotechCorp's value examination focuses on studying past and present price action to predict the probability of Legend BiotechCorp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Legend BiotechCorp's price. Additionally, you may evaluate how the addition of Legend BiotechCorp to your portfolios can decrease your overall portfolio volatility.
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Stocks Directory
Find actively traded stocks across global markets
Equity Valuation
Check real value of public entities based on technical and fundamental data
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Is Legend BiotechCorp's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Legend BiotechCorp. If investors know Legend will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Legend BiotechCorp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(2.94)
Revenue Per Share
1.619
Quarterly Revenue Growth
1.876
Return On Assets
(0.17)
Return On Equity
(0.52)
The market value of Legend BiotechCorp is measured differently than its book value, which is the value of Legend that is recorded on the company's balance sheet. Investors also form their own opinion of Legend BiotechCorp's value that differs from its market value or its book value, called intrinsic value, which is Legend BiotechCorp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Legend BiotechCorp's market value can be influenced by many factors that don't directly affect Legend BiotechCorp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Legend BiotechCorp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Legend BiotechCorp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Legend BiotechCorp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.